Bart L Haagmans
Overview
Explore the profile of Bart L Haagmans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
221
Citations
22817
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Breugem T, Riesebosch S, Zhang J, Mykytyn A, Krabbendam L, Groen N, et al.
Proc Natl Acad Sci U S A
. 2025 Mar;
122(11):e2410630122.
PMID: 40048293
Transmissibility of respiratory viruses is a complex viral trait that is intricately linked to tropism. Several highly transmissible viruses, including severe acute respiratory syndrome coronavirus 2 and Influenza viruses, specifically...
2.
Rissmann M, Noack D, Spliethof T, Vaes V, Stam R, van Run P, et al.
PLoS Pathog
. 2025 Jan;
21(1):e1012875.
PMID: 39841788
Orthohantaviruses are emerging zoonotic viruses that can infect humans via the respiratory tract. There is an unmet need for an in vivo model to study infection of different orthohantaviruses in...
3.
Brangel P, Tureli S, Muhlemann B, Liechti N, Zysset D, Engler O, et al.
Viruses
. 2025 Jan;
16(12).
PMID: 39772242
Setting up a global SARS-CoV-2 surveillance system requires an understanding of how virus isolation and propagation practices, use of animal or human sera, and different neutralisation assay platforms influence assessment...
4.
Beythien G, de le Roi M, Stanelle-Bertram S, Armando F, Heydemann L, Rosiak M, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39518980
The SARS-CoV-2 pandemic has highlighted the challenges posed by the emergence and rapid global spread of previously unknown viruses. Early investigations on the pathogenesis of newly identified viruses are often...
5.
Raadsen M, Dahlke C, Fathi A, Hardtke S, Kluver M, Krahling V, et al.
Lancet Infect Dis
. 2024 Oct;
25(2):231-242.
PMID: 39389076
Background: MERS-CoV is a respiratory pathogen with a case-fatality rate of 36%, and for which no vaccines are currently licensed. MVA-MERS-S is a candidate vaccine based on recombinant modified vaccinia...
6.
Weskamm L, Tarnow P, Harms C, Huchon M, Raadsen M, Friedrich M, et al.
iScience
. 2024 Aug;
27(8):110470.
PMID: 39148710
Besides neutralizing antibodies, which are considered an important measure for vaccine immunogenicity, Fc-mediated antibody functions can contribute to antibody-mediated protection. They are strongly influenced by structural antibody properties such as...
7.
Veugen J, Schoenmakers T, van Loo I, Haagmans B, Leers M, Lamers M, et al.
Microbiol Spectr
. 2024 Jul;
12(9):e0016024.
PMID: 39037224
Importance: This study developed a novel method that can help determine whether someone who has been diagnosed with coronavirus disease 2019 (COVID-19) is still capable of spreading the virus to...
8.
Geers D, Gommers L, Tan N, Bogers S, van Baarle D, Grifoni A, et al.
Lancet Infect Dis
. 2024 Jun;
24(8):e477-e478.
PMID: 38909615
No abstract available.
9.
van Dijk L, Rijsbergen L, Rubio B, Schmitz K, Gommers L, Comvalius A, et al.
Cell Mol Life Sci
. 2024 Jun;
81(1):267.
PMID: 38884678
Neutralizing antibodies are considered a correlate of protection against severe human respiratory syncytial virus (HRSV) disease. Currently, HRSV neutralization assays are performed on immortalized cell lines like Vero or A549...
10.
Rossler A, Netzl A, Knabl L, Wilks S, Muhlemann B, Tureli S, et al.
NPJ Vaccines
. 2024 May;
9(1):85.
PMID: 38762525
Antigenic characterization of newly emerging SARS-CoV-2 variants is important to assess their immune escape and judge the need for future vaccine updates. To bridge data obtained from animal sera with...